This genetic signature marker contains LRP12, CCND1, EGFR and TPM2 genes that could predict clinical outcomes and facilitate selection of therapeutic strategies in oral cancer management that are tailor-made for patients. Here, CCND1 is linked to lip and oral cavity carcinoma.